Document Detail


Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction.
MedLine Citation:
PMID:  11841524     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction. DESIGN: Telephone survey and administrative data. SETTING: National managed-care company. PARTICIPANTS: Six hundred ninety-six adults age 30 to 64 surveyed in 1999, approximately 1 to 2 years after a myocardial infarction. MEASUREMENTS: Use of cholesterol-lowering drugs, beliefs about the importance of lowering cholesterol, and knowledge of personal cholesterol level, adjusting for demographic and clinical factors with logistic regression. MAIN RESULTS: Among respondents, 62.5% reported they were taking a cholesterol-lowering drug. In adjusted analyses, these drugs were used significantly less often by African-American patients and those with congestive heart failure or peripheral vascular disease, and more often by college graduates, patients with hypertension, and those who had seen a cardiologist since their myocardial infarction. Lowering cholesterol was viewed as "very important"; by 87.1% of patients, but significantly less often by smokers and more often by those who had undergone coronary angioplasty or bypass surgery. Only 42.5% of respondents knew their cholesterol level, and this knowledge was significantly less common among less-educated or less-affluent patients, African-American patients, and patients who smoked or had diabetes or peripheral vascular disease. CONCLUSIONS: Although most patients recognized the importance of lowering cholesterol after myocardial infarction, several clinical and demographic subgroups were less likely to receive cholesterol-lowering therapy, and many patients were unaware of their cholesterol level. Health-care providers and managed-care plans can use these findings to promote cholesterol testing and treatment for patients with coronary heart disease who are most likely to benefit from these efforts.
Authors:
John Z Ayanian; Bruce E Landon; Mary Beth Landrum; James R Grana; Barbara J McNeil
Related Documents :
20690094 - The effect of early and intensive statin therapy on ventricular premature beat or non-s...
15147434 - Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipi...
11779514 - Usefulness of lipoprotein changes during acute coronary syndromes for predicting postdi...
21373944 - Unusual capture of a capture beat : lessons learned from the 12-lead electrocardiogram.
15664554 - Functional diagnosis of coronary stenosis using tissue tracking provides best sensitivi...
8903294 - Regression of st segment elevation after thrombolysis in acute aortic dissection.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of general internal medicine     Volume:  17     ISSN:  0884-8734     ISO Abbreviation:  J Gen Intern Med     Publication Date:  2002 Feb 
Date Detail:
Created Date:  2002-02-13     Completed Date:  2002-03-21     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  8605834     Medline TA:  J Gen Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  95-102     Citation Subset:  IM    
Affiliation:
Department of Medicine, Division of General Medicine and Primary Care, Brigham and Women's Hospital and Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA. ayanian@hcp.med.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Antilipemic Agents / administration & dosage*
Confidence Intervals
Female
Health Knowledge, Attitudes, Practice*
Humans
Logistic Models
Male
Middle Aged
Myocardial Infarction / diagnosis,  prevention & control*
Odds Ratio
Population Surveillance
Prognosis
Questionnaires
Recurrence / prevention & control
Risk Assessment
Risk Factors
Sex Factors
Chemical
Reg. No./Substance:
0/Antilipemic Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tensions in antibiotic prescribing: pitting social concerns against the interests of individual pati...
Next Document:  Barriers to initiating depression treatment in primary care practice.